DZ Bank’s Antares Pharma, Inc. ATRS Stock Holding History

DZ Bank’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-216,709	Closed	-$477K	–	1142
2018 Q1	$477K	Buy	+216,709	New	+$488K	﹤0.01%	799

Other funds holding ATRS

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MWP

MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DZ Bank's ATRS Position: Q2 2018 in Review

DZ Bank sold out of Antares Pharma, Inc. (ATRS) in Q2 2018, closing a stake of 216,709 shares — an estimated $477K sold.

DZ Bank first reported a position in ATRS in Q1 2018 and held it in 1 quarter. The position peaked at $477K in Q1 2018. 101 funds tracked by Wall St. Rank hold ATRS as of Q2 2018.

DZ Bank reported no remaining Antares Pharma, Inc. position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 216,709 Antares Pharma, Inc. shares in Q2 2018, an estimated $477K.
DZ Bank first reported a position in Antares Pharma, Inc. in Q1 2018 and held it in 1 quarter.
DZ Bank's Antares Pharma, Inc. position peaked at $477K in Q1 2018.
101 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.